Page 31 - MemoriaDEM-Eng

www.ciberdem.org

GLOBAL PREVALENCE DATA ([email protected] STUDY)

% of affected No. of affected
individuals over 18 individuals over 18

years of age
years of age
Known diabetes mellitus
7,78
3.111.641

Unknown diabetes mellitus
6,01
1.514.916

Total diabetes mellitus
13,79
4.626.557

Abnormal tolerance to glucose
9,21
3.028.706

Impaired fasting glucose
3.44
1.398.183

Obesity 1
28.21
10.863.431

Arterial hypertension
41.20
15.889.058
á

Metabolic syndrome
20.82
8.022.026
á
éé
Smoking 27.81 10.724.238
á
íí
Daily intake of alcoholic beverages
22.62
8.733.905

Intake of olive oil for frying
69.20
26.583.402
óó
é
Sedentary lifestyle
50.31
19.400.237
í

íú
é
According to the [email protected] study, the total prevalence of DM2 in Spain is 13.79%.
It is worth highlighting that 6% of those suffering the disease are unaware of it. On
é
the other hand, three out of every ten Spanish people suffer obesity and four out
of every ten suffer arterial hypertension.
í

ñ
Most relevant publications in 2013
ó

í
• R-M G, V s, C n, l MI, G s, G R, C R, C
ojoaRtnezaldsoloMouCenaaztaMbIdeoMIsasaMItjanaaRMena
R, Catal M, MaRtnez-laRRad Mt, seRRano-Ríos M, Castaño l, VendRell j, GIRbés j, FRanCh j,
V ja, M-P I, u I, P-M G, o e, M e, d e, b
zquezoRaeCesRRutIaasCualanIChRteGaenéndezelGadooRdIúé
e, Castell C, lPez-alba a, Goday a, Calle a, bosCh-CoMas a, soRIGueR F. Use of Drugs Related é
to the Treatment of Diabetes Mellitus and Other Cardiovascular Risk Factors in the Spanish é

Population. The [email protected] Study. Rev Esp Cardiol (Engl Ed). 2013 Nov;66(11):854-63.
doi: 10.1016/j.rec.2013.05.027. Epub 2013 Sep 23. PubMed PMID: 24773992.
áñá
• s F, R-M G, G a, b-C a, bú e, C-d F, C-P
oRIGueRojoaRtnezodayosChoMasoRdIaballeRoíazalleasCualí
a, CaRMena R, CasaMItjana R, Castao l, Castell C, Catal M, delGado e, FRanCh j, GaztaMbIde
s, G j, G R, G G, l-a a, t M-l M, M e, M-
IRbsoMIsutIRRezPezlbaeResaaRtnezaRRadenéndezoRa
PeCes I, oRteGa e, PasCual-ManICh G, seRRano-RIos M, uRRutIa I, Valdés s, antonIo Vázquez
j, V j. Olive oil has a beneficial effect on impaired glucose regulation and other á
endRellñ
cardiometabolic risk factors. [email protected] study. Eur J Clin Nutr. 2013 Sep;67(9):911-6. doi: 13
10.1038/ejcn.2013.130. Epub 2013 Jul 17. PubMed PMID: 23859999.
ó20
T
• o e, F j, C C, G a, R-b l, s F, V j, C R, OR
RteGaRanChastellodayIbasaRbaoRIGueRendRellasaMItjanaP
bosCh-CoMas a, boRdI e, Calle-PasCual a, CaRMena R, Castao l, Catal M, delGado e, GaztaMbIde ñRE
s, G j, l-a a, M-l Mt, M e, M-P I, P-M G, L
IRbsPezlbaaRtnezaRRadenndezoRaeCesasCualanIChA
Rojo-MaRtnez G, seRRano-RIos M, uRRuta I, Valds s, Vzquez ja, GoMIs R. Mediterranean NU
diet adherence in individuals with prediabetes and unknown diabetes: the [email protected] N
A
Study. Ann Nutr Metab. 2013;62(4):339-46. doi: 10.1159/000346553. Epub 2013 Jul 2. éM /
PubMed PMID: 23838479.
íE
D
• M C, C-P al, F M, R I, R Ma, M C, R-M G, ER
aRCuelloalleasCualuentesunkleubIoontaezojoaRtInezB
soRIGueR F, boRdIu e, Goday a, bosCh-CoMas a, CaRMena R, CasaMItjana R, Castao l, Castell C, CI

Catal M, delGado e, FRanCh j, GaztaMbIde s, GIRbs j, GoMIs R, uRRutIa I, lPez-alba a, MaRtnez- 31
laRRad Mt, Menndez e, MoRa-PeCes I, oRteGa e, PasCual-ManICh G, seRRano-RIos M, Valds s,